Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Safety phase of lactoferrin study completed

May 27, 2003

TroVax trial in renal cancer cleared to begin

May 22, 2003

Preliminary phase II Onyvax-P results

May 19, 2003

Evidence of cytotoxic effects of IL-13-PE38QQR in brain cancer

May 19, 2003

Second Merck antibody advances to phase II trials

May 12, 2003

Xcyte T-cell product enters phase I/II trial in multiple myeloma

May 12, 2003

Initiation of phase I clinical trial of TTS-CD3 in patients with NSCLC

May 12, 2003

Phase I trial of HER-2 Protein AutoVac cleared to begin

May 7, 2003

Enrollment completed in phase IIa Onyvax-P trial

May 5, 2003

Potentially more effective BCG-based therapy for bladder cancer discussed at AUA meeting

April 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...